New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
10:01 EDTPHG, LLY, AEGN, RXN, PNR, CTCM, TTM, QSII, TV, BRO, RUSHAOn The Fly: Analyst Downgrade Summary
Aegion (AEGN) downgraded to Neutral from Buy at Sidoti... Brown & Brown (BRO) downgraded to Neutral from Buy at Compass Point... CTC Media (CTCM) downgraded to Underperform from Neutral at Credit Suisse... Eli Lilly (LLY) downgraded to Neutral from Buy at MKM Partners... Grupo Televisa (TV) downgraded to Underperform from Neutral at BofA/Merrill... Pentair (PNR) downgraded to Neutral from Outperform at Wedbush... Philips (PHG) downgraded to Sector Perform from Outperform at RBC Capital... Quality Systems (QSII) downgraded to Underweight from Equal Weight at Morgan Stanley... Rexnord (RXN) downgraded at BofA/Merrill... Rush Enterprises (RUSHA) downgraded to Equal Weight from Overweight at Stephens... Tata Motors (TTM) downgraded to Neutral from Outperform at Credit Suisse.
News For AEGN;BRO;CTCM;LLY;TV;PNR;PHG;QSII;RXN;RUSHA;TTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2015
06:56 EDTPNRPentair initiated with a Neutral at Global Hunter
Subscribe for More Information
05:46 EDTPHGPhilips wise to sell Lumileds stake, DigiTimes Research reports
Subscribe for More Information
05:29 EDTQSIINextGen, Milliman enter into agreement for analytics, risk scoring services
Subscribe for More Information
April 13, 2015
10:00 EDTPNROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:46 EDTCTCMCTC Media launches free movie streaming services
Subscribe for More Information
07:31 EDTQSIIHealthcare Information & Management Systems Society to hold a conference
HIMSS 2015 is being held in Chicago on April 12-16.
07:29 EDTQSIILeerink to hold booth tours at HIMSS
Subscribe for More Information
06:54 EDTPNRPentair downgraded to Hold from Buy at BB&T
Subscribe for More Information
April 10, 2015
11:13 EDTQSIILeerink healthcare services analyst holds analyst/industry conference call
Subscribe for More Information
11:03 EDTLLYEli Lilly granted orphan status for anal cancer treatment
Subscribe for More Information
April 9, 2015
10:00 EDTRXNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:25 EDTLLYPiper Jaffray pharmaceuticals analysts hold an analyst/industry conference call
Subscribe for More Information
07:11 EDTRXNRexnord downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Rexnord to Hold after lowering its estimates to reflect currency headwinds and a lack of evidence for a pickup in North American capital spending. The firm cut its price target for shares to $27 from $30.
05:36 EDTQSIIQuality Systems acquires Gennius
Subscribe for More Information
April 8, 2015
09:20 EDTPNROn The Fly: Pre-market Movers
Subscribe for More Information
April 7, 2015
19:10 EDTPNROn The Fly: After Hours Movers
Subscribe for More Information
16:23 EDTPNRPentair lowers Q1 EPS view to about 65c from 75c-77c, consensus 77c
Subscribe for More Information
16:19 EDTPNRPentair lowers Q1 outlook
Subscribe for More Information
07:14 EDTLLYEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
April 6, 2015
07:14 EDTLLYBiodel GEM device demonstrates 'superior' usability
Biodel (BIOD) announced results from a formative human factors study of its Glucagon Emergency Management, or GEM, device, which is in development for the treatment of diabetes patients experiencing severe hypoglycemia. In the study, the GEM device demonstrated a substantial improvement in ease-of-use and successful delivery of the full dose, as well as a reduction in dosing errors, when compared to commercially available glucagon kits; Eli Lilly's (LLY) Glucagon Emergency Rescue Kit and Novo Nordisk's GlucaGen HypoKit. Furthermore, while training and previous experience increased the success rate with the Eli Lilly and Novo Nordisk glucagon kits, it did not further impact the already high success rate with the GEM device when compared to non-experienced, untrained participants.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use